Abstract
Background
Respiratory syncytial virus (RSV) causes exacerbations of asthma and preschool wheeze (PSW). However, the anti-viral and repair responses of the bronchial epithelium in children with severe therapy resistant asthma (STRA) and PSW are poorly understood.
Methods
Children with STRA (age 12 [6-16] years), PSW (age 2 [1-5] years) and non-asthmatic controls (age 7 [2-14] years) underwent bronchoscopy with endobronchial brushings and biopsies. Anti-viral, wound injury responses were quantified in biopsies and primary bronchial epithelial cells (PBECs) in response to RSV, poly(I:C), house dust mite (HDM) or IL-33 using RT-qPCR, Luminex and live cell imaging. Collagen deposition and tissue expression of epithelial growth factor receptor (EGFR), IL-33 and receptor ST2 was investigated in bronchial biopsies.
Results
PBECs from STRA and PSW had increased TLR3 gene expression and increased secretion of anti-viral and pro-inflammatory cytokines (IFN-γ, IL-6 and IL-13) in response to RSV compared to controls. Exposure of PBECs to concomitant TLR3 agonist poly(I:C) and HDM resulted in a significant reduction in epithelial cell proliferation in PSW compared to controls. Wound-healing was also impaired in PSW compared to controls at baseline and following IL-33 stimulation. In addition, tissue EGFR expression was significantly reduced in PSW and correlated with collagen deposition in endobronchial biopsies.
Conclusions
Despite increased anti-viral responses, preschool children with severe wheeze had impaired airway epithelial proliferative responses following damage. This might be connected to the low expression of EGFR in PSW which may affect epithelial function and could contribute to asthma pathogenesis.
Keywords: epithelium, paediatric asthma, RSV, severe therapy resistant asthma, wheeze
Introduction
Wheezing in response to viral infections during infancy and preschool years is often the first clinical manifestation of asthma development in childhood (1). However, not all children who wheeze with viral infections will develop asthma (1). Infection with either human rhinovirus (RV) or respiratory syncytial virus (RSV) is associated with early wheeze and asthma development (2–5). RSV infection is considered particularly important in more severe early wheeze, resulting in hospitalisation (6). Early allergic sensitization together with virus associated wheezing further increases the risk of asthma development (7, 8).
Most children with asthma have mild or moderate disease and achieve symptom control with maintenance-inhaled steroids (9, 10). However, a small proportion have persistent symptoms despite maximal dose treatment including long and short acting inhaled β2-receptor agonists, inhaled corticosteroids (ICS) and/or leukotriene receptor antagonists (11), and after addressing adherence and factors such as allergen and smoke exposure. These children have severe therapy resistant asthma (STRA) (12). The airway epithelium acts as the first line of defense against harmful environmental insults such as infectious pathogens and allergens, and it has been suggested that abnormal responses to these exposures could lead to asthma pathology (13). In support of this, epithelial damage has been reported in both adult and childhood asthma (14, 15). A functioning re-epithelialization of the airways is required to maintain the integrity of its immune and barrier function (16). Since RSV replication is restricted to airway epithelial cells, and induces potent expression of cytokines and chemokines, the epithelium is postulated to be a primary initiator of pulmonary inflammation during RSV infection. Many prospective long-term follow-up studies have shown that RSV-induced bronchiolitis is associated with later development of asthma, especially in those with severe disease (3, 17, 18). Studies have also reported an association between RSV-induced bronchiolitis and subsequent allergic sensitization (2, 19–21). RSV infections have shown to reduce IFN expression in peripheral blood mononuclear cells as well as in T-cell populations, and has been correlated with subsequent asthma (22–25). A recent study studies showed that RSV-induced EGFR activation suppresses IFN production from epithelial cells and increase RSV infection in infants (26).
The epithelial cytokine IL-33 have been shown to increase during viral induced asthma exacerbations in adults with mild to moderate disease (27, 28). However, very little is known about airway epithelial function in severe preschool wheeze patients despite the fact that wheezing with viruses is particularly common in preschool children and there are currently few effective treatment strategies for viral wheeze (29). We have previously reported that STRA children had increased submucosal expression of IL-33 which related to reticular basement membrane thickness (30). We and others have also reported increased sub-epithelial reticular basement membrane thickness in severe preschool wheezers (31, 32), but the relationship between epithelial function and remodelling has not been investigated.
We hypothesised that children with severe preschool wheeze (PSW) and STRA would have impaired epithelial inflammatory and repair responses to RSV infection compared to controls, and this would be influenced further by exposure to the aeroallergen house dust mite (HDM) or IL-33. We investigated this by assessing the functional properties, expression of anti-viral and pro-inflammatory responses following exposure to IL-33 and RSV, alone or in the presence of HDM, in PBECs from preschool children with severe, recurrent wheeze and school-aged children with STRA in comparison to non-asthmatic controls. In addition, we investigated tissue expression collagen, epithelial growth factor receptor (EGFR), IL-33 and ST2 expression in bronchial biopsies from the same patient groups.
Material and Methods
Subjects
10 school-aged children with STRA (22) (median age 12 [range 6-16] years) and 7 preschool children with severe, recurrent wheeze (median age 2 [range 1-5] years) were recruited from the Royal Brompton Hospital. Children with STRA and PSW underwent a clinically indicated bronchoscopy and additional research endobronchial brushings and biopsies were taken during the procedure with parental informed consent (4). Non-asthmatic control subjects were undergoing clinically indicated bronchoscopy and agreed to research samples being taken at the same time (n=5). Successful epithelial cell cultures were established from 4 of these, although all 5 had adequate biopsies taken. In addition, normal bronchial epithelial cells from 2 paediatric healthy donors were purchased from Lonza. See Table 1 and online repository (OR) for details. The study was approved by the NRES Committee London - Chelsea.
Table 1. Demographics of control, wheeze and STRA patients undergoing bronchoscopy.
| Non-asthmatic controlsⱠ (n=7) | Pre-school wheeze (n=7) | STRA (n=10) | p-value | |
|---|---|---|---|---|
| Atopy | 2/7 (29%) | 0/7 (0%) | 9/10 (90%) | 0.08 |
| Male: Female | 3:4 | 3:4 | 6:4 | |
| Age, years | 7 (2-14) | 2 (1-5) | 12 (6-16) | 0.01 |
| Weight (Kg) | 36 (28-48) | 12.4 (8.7-25) | 37 (21-88) | 0.0009 |
| Height (cm) | 146 (137-156) | 91 (73-126) | 142 (103-186) | 0.002 |
| Intubation for asthma | - | 3 | 2 | |
| Total IgE(IU/ml) | 86 (9-180) | 18 (1-42) | 505 (29-4847) | 0.003 |
| Sum of inhalant sIgE (IU/mL) | 0 (0-0) | 0 (0-0) | 4.5 (1-2) | <0.0001 |
| Sum of all slgE (lU/mL) | 0 (0-0) | 0 (0-0) | 1 (1-2) | <0.0001 |
| BAL Neutrophils(%)¶ł | 4.0 (3.7-10.3) | 11.0 (3.0-19.0) | 6.0 (0.3-21.7) | 0.9 |
| BAL Eosinophils (%)** | 1.3 (1.0-4.0) | 1.5 (1.0-2.0) | 5.0 (0.3-10) | 0.6 |
| Blood Eosinophils (%) | 3.1 (1.5-4.4) | 3.9 (0.9-6.1) | 6.6 (2.2-15.9) | 0.2 |
| Blood Neutrophils (%) | 49.2 (47.0-55.0) | 34.3 (22.2-58.3) | 50.0 (29.1-75.8) | 0.08 |
| ACT score | - | - | 15 (11-16) | |
| Baseline FEV1 (litres) | - | - | 1.9 (0.8-3.7) | |
| Baseline % predicted FEV1* | - | - | 83 (47-112) | |
| Number FEV1 ‘normal’ (>80% predicted) | - | - | 5 | |
| Baseline FVC (litres) | - | - | 2.6 (1.0-4.6) | |
| Baseline % predicted FVC | - | - | 109 (75-126) | |
| Baseline bronchodilator reversibility (%) | - | - | 7 (0-49) | |
| Medications | ||||
| Daily dose Inhaledǂ corticosteroid (mcg/day) | 0 (0-0) | 350 (0-500) | 1000 (1000-2000) | |
| Budesonide equivalent | ||||
| Leukotriene receptor antagonist | 2 of 6 (33%) | 3 of 7 (43%) | 6 of 10 (60%) | |
| Systemic corticosteroids | ||||
| Daily dose (mg/day) | 0 | 0 | 10 (0-20) | |
| Theophylline | 0 | 0 | 3 |
Data presented as median (range).
5 non-asthmatic controls were undergoing clinically indicated bronchoscopies and had agreed to a research bronchoscopy: brushings were collected from 4 and biopsies from 5 subjects. HBECs from 2 non-asthmatic controls were also bought from Lonza. For details see OR.
BAL Neutrophils (<3% is normal).
BAL eosinophils (<3% is normal).
FEV1: presented as percentage predicted.
ICS: inhaled corticosteroids/day. Differences between groups were assessed by Mann-Whitney test or Chi-square test where P<0.05 is significant.
Epithelial cell culture and stimulation
Primary bronchial epithelial cells (PBECs) were seeded into collagen coated tissue culture flasks containing BEGM (Lonza, Walkerville, Md) and used at passage 3 at 80% confluency (except for proliferation) for all experiments. PBECs were stimulated with RSV, with and without concomitant exposure to house dust mite (HDM) (Greer, London, UK). Proliferation and wound-injury measurements were performed using the TLR3 agonist ds RNA poly(I:C) and recombinant IL-33. For details see OR.
Assessment of proliferation and wound repair
The ability of airway epithelial cells to proliferate and repair wounds following exposure to HDM, poly I:C and IL-33 were assessed by image analysis using the IncuCyte live-cell imaging system (Essen Bioscience, Ann Arbor, MI, USA). For proliferation assays, cells were monitored for a total of 60 hours. The density of cells was calculated by IncuCyte S3 Software (Essen Bioscience) and expressed as occupied area (% confluence). For wound-injury assays, PBECs were grown in BEGM until >80% confluent and cell monolayers were wounded with a single scratch. Cultures were monitored for 48 hours. Results were normalised to each patient’s non-stimulated control. For details see OR.
RNA extraction and real-time PCR
Total RNA was extracted from epithelial cells using the Qiagen RNeasy Micro Kit (Qiagen, Hilden, Germany). cDNA was synthesized and analysed using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster city, CA. Gene expression was measured using TaqMan primers for specific genes with Taqman Fast Advanced Master Mix (Life technologies) and performed on Viia7 system (Applied Biosystems). For details see OR.
Quantification of cytokines
Cell culture supernatant was collected and cytokines analysed using a customised Milliplex panel (Millipore Corporation, Billerica, Mass) for human cytokines and chemokines (see OR). Soluble ST2 (sST2) was measured using ELISA according to manufacturer’s instructions (R&D Systems, Abingdon, United Kingdom).
Western Blots and densitometry
ST2 protein was detected in protein lysates and α-Tubulin was used as a loading control and detected using a peroxidase–conjugated anti-rabbit antibody. Membranes were developed with ECL substrate (Pierce, Cheshire, United Kingdom) and developed in ECL plus western blotting detection system prior to imaging and quantification of band density (intensity per area) on the myECL Imager (Thermo Fisher Scientific). For details see OR.
Histopathology
Endobronchial biopsies were fixed in 4% paraformaldehyde processed to paraffin. Consecutive sections were used for immunohistochemical staining for IL-33, ST2, and epidermal growth factor receptor. Antibodies were visualised using DAKO Envision system (Dako) according to manufacturer’s directions. Positive staining was quantified manually (number of cells/area of tissue) or as positivity (positive brown pixels divided by all stained pixels) using computerised image analysis on blinded sections using ImageScope (Aperio, Vista, CA). For details see OR.
Statistical analysis
Sample size was opportunistic since there are no data to inform a power calculation. Nonparametric tests including Mann-Whitney U test and Kruskal Wallis test with Bonferroni post hoc test were used to detect differences between 2 groups or more than 2 groups, respectively, using GraphPad Prism 6 (GraphPad Software, La Jolla, CA). Correlations were assessed using the Spearman rank correlation test. p<0.05 was considered significant.
Results
PBECs from preschool wheezers and children with STRA had increased secretion of anti-viral, Th1 and Th2 mediators in response to RSV
Anti-viral response
PBECs from children with PSW and STRA had increased secretion of IFN-γ in response to RSV compared to non-asthmatic controls (NA) (Figure 1A). This was also true for STRA compared to NA when stimulated with HDM+RSV. No difference in TNF-α or CXCL10 secretion was found between the groups (Figure 1B–C). IL-6 was increased in PSW and children with STRA compared to NA when stimulated with RSV alone and RSV+HDM in combination (Figure 1D).
Figure 1.
Protein secretion in response to RSV infection and HDM stimulation in PBECs from paediatric non-asthmatic controls (NA) (n=6), wheezers (n=7) and children with STRA (n=10) using a custom made Milliplex assay. PBECs were stimulated with media alone, HDM, RSV and HDM and RSV in combination and epithelial cell supernatants analysed at 24 hours post infection: IFN-γ (A), TNF-α (B), CXCL10 (IP-10) (C), IL-6 (D), IL-8 (E), GRO (F), and IL-13 (G), FGF-2 (H), VEGF (I) and viral load (J). Statistical analysis was performed with Kruskall-Wallis test with post hoc test where *P<0.05, **<0.01 and ***<0.001.
Type1 and Type2 cytokines
PBECs from children with STRA had increased secretion of neutrophil attractant chemokines IL-8 and GRO in response to RSV alone or in combination with HDM compared to NA and PSW (Figure 1E–F). Children with PSW and STRA had enhanced secretion of the type 2 cytokine IL-13 from PBEC when stimulated with RSV or RSV+HDM in combination (Figure 1G).
Viral load and replication
No differences in viral load for RSV between non-asthmatic controls, PSW and children with STRA were found, indicating similar viral replication in PBECs between the groups. UV inactivated virus had impaired viral replication as shown by measurements of viral RNA (Figure 1J). Thus, PBECs from STRA and PSW had increased secretion of anti-viral and pro-inflammatory mediators in response to RSV alone, or in combination with HDM, compared to NA.
PBECs from preschool wheezers and children with STRA had an altered gene expression pattern when stimulated with HDM and RSV when compared to non-asthmatic controls
Gene expression of 16 genes (TLR3, MDA5, RIGI, IFN-α, IFN-γ, OAS2, IRF3, CXCL10, IL6, CXCL8, ICAM-1, CAR, PCDH1, GCR, EGFR and AREG) related to anti-viral response, pro-inflammatory markers and epithelial growth and repair in epithelial cell samples was evaluated using a fold change heatmap (Figure 2). Red represents increased expression and green represents decreased expression and data are presented for non-stimulated cells (Figure 2A) as well as cell cultures stimulated with HDM (Figure 2B), RSV (Figure 2C) and RSV+HDM (Figure 2D). Data showed a distinct pattern of increased gene expression of anti-viral and proinflammatory mediators in STRA and PSW compared to non-asthmatic controls. Gene expression as individual graphs are shown in Fig E1 in OR.
Figure 2.
Gene expression heatmap of non-stimulated cells (A) as well as in response to HDM stimulation (B), RSV infection (C) or RSV and HDM in combination (D) in PBECs from paediatric non-asthmatic controls (NA) (n=6), wheezers (n=7) and children with STRA (n=10). Epithelial cells were analyzed at 8 hours post infection. Data is showed as log2 fold change values (top) and tables with foldchange values (bottom) for TLR3, MDA5, RIGI, IFN-α, IFN-γ, OAS2, IRF3, CXCL10 (IP-10), IL-6, CXCL8 (IL-8), ICAM-1, CAR, PCDH1, GCR, EGFR and AREG. Red and green represent greater and lower expression in compared to non-stimulated non-asthmatic controls, respectively.
Bronchial epithelial cells from preschool wheezers had impaired proliferation and wound-healing compared to STRA and non-asthmatic controls
Having seen increased anti-viral and pro-inflammatory responses to RSV infection in PBECs, we investigated epithelial function by assessing proliferation and wound healing abilities of PBECs from severe preschool wheezers, children with STRA and paediatric NA in response to poly(I:C) (a viral mimic) and allergen (HDM).
Analysis per timepoint
Overall, PBECs from children with PSW proliferated very poorly over the selected time period (Fig 3A–D). Exposure of PBEC to concomitant poly(I:C) and HDM at 60 hours resulted in a significant reduction in proliferation in PSW compared to non-asthmatic controls (Figure 2D). The ability of epithelial cells to heal scratch wounds, measured as percentage of wound closure, was also impaired in PSW compared to controls at baseline (Figure 3E) at 48 hours.
Figure 3.
Proliferation (A-D) and wound-injury assay (E-H) in PBECs from paediatric non-asthmatic controls (NA) (n=6), PSW (n=7) and children with STRA (n=10). PBECs were stimulated with media alone (A, E), HDM (B, F), viral mimic poly(I:C) (C, G) and HDM and poly(I:C) in combination (D, H). Data as plotted as area under curve (AUC) for proliferation (I) and wound-healing (J). Statistical analysis was performed with Kruskall-Wallis test with Bonferroni post hoc test for each time point. * denotes differences between PSW and media control. # denotes differences between PSW and STRA and + denotes differences between media control and STRA. *P<0.05 was considered significant.
Area under curve
By comparing area under curve between the groups for each stimuli we found that PSW had significantly lower proliferation than NA and STRA at baseline (media alone) and with all stimuli. PBECs from children with STRA had lower proliferation than NA when stimulated with HDM and poly(I:C) in combination (Figure 3I). By comparing area under curve for wound-healing we found that PSW had significantly lower wound healing abilities than NA at baseline (media alone) and a tendency when stimulated with HDM (p=0.07) (Figure 3J).
Only children with STRA had increased epithelial and submucosal expression of the IL-33 receptor ST2
We have previously determined that IL-33 expression is increased in STRA patients, and is potentially involved in airway remodelling (30). Having found abnormal epithelial wound injury and elevated Th2 responses following RSV infection, we determined the expression of IL-33 and its receptor ST2 in cultured PBECs in response to RSV and HDM. We confirmed in this new patient cohort an increase in IL-33 positive cells in the submucosa in STRA biopsies compared to controls (Figure 4A–C), but no difference in epithelial IL-33 expression between the groups (Figure 4D). Tissue expression of ST2 was increased in STRA compared to controls in both the submucosa and epithelium (Figure 4E–H). However, neither IL-33 nor ST2 was differentially expressed in biopsies from PSW compared to controls. Gene expression of ST2 was similar between the groups at baseline and following stimulation with RSV (Figure 4I). Epithelial ST2 protein levels were increased in both PSW and STRA compared to controls when stimulated with RSV+HDM (Figure 4J).
Figure 4.
Submucosal and epithelial tissue expression of IL-33 (A-D) and ST2 (E-H) in bronchial biopsies from paediatric non-asthmatic controls (NA) (n=5), wheezers (n=7) and children with STRA (n=10). Scale bars: A and E: 50 μm and B and F: 100 μm. One control subjects was excluded due to inadequate tissue sample. PBECs were stimulated with media alone, HDM, RSV and HDM and RSV in combination and gene (I) and protein (J) expression of ST2 in response to RSV and HDM in PBECs from paediatric non-asthmatic controls (n=6), wheezers (n=6) and children with STRA (n=9) was measured. Three subjects (1, non-asthmatic control, 1 wheeze and 1 STRA) were excluded due to inadequate RNA/protein concentrations. Statistical analysis was performed with Kruskall-Wallis test with Bonferroni post hoc test where *P<0.05 and **<0.01.
Epithelial expression of the IL-33 receptor ST2 was only increased in children with STRA in bronchial biopsies, although expression was increased in both STRA and PSW PBECs stimulated with RSV and HDM.
IL-33 was associated with both tissue collagen deposition and EGFR expression in preschool wheezers and children with STRA
Since IL-33 has been shown to induce extracellular matrix protein deposition (27) and associated with remodelling (30), we investigated the tissue density of collagen in endobronchial biopsies using trichrome staining. The staining displayed positivity (blue colour) for collagen in the submucosal region as well as in the reticular basement membrane (33). The density of collagen was increased in the submucosa in STRA compared to PSW (Figures 5A–D). To investigate the association between tissue expression of IL-33 and collagen, a correlation analysis was performed, showing a positive correlation between IL-33 and collagen density in both STRA and PSW (Figure 5E) but no significant correlation in non-asthmatic controls (Figure 5F). Since PBECs from PSW had impaired proliferation and wound-healing we investigated the tissue expression of the epidermal growth factor receptor (EGFR). The immunohistochemical staining for EGFR displayed a positive signal in the basal layer of the epithelium close to the reticular basement membrane, and staining is in accordance with previous literature (34). Tissue expression of EGFR was lower in PSW compared to both non-asthmatic controls and STRA (Figures 5G–J). As the whole control group were not specifically age-matched to PSW, we compared epithelial EGFR expression in PSW (mean age 2 years) and age-matched non-wheezers (mean age 2.7 years). Epithelial EGFR expression remained significantly reduced in PSW compared to age-matched controls (Fig 5K). We found no significant correlation between EGFR expression and age in the control and PSW groups (see OR, Fig E2A-C). There was a positive correlation between EGFR and collagen density in STRA and PSW but no significant correlation in non-asthmatic controls (see OR, Fig E2D-E). Children with PSW had reduced epithelial EGFR expression compared to controls, while children with STRA had increased tissue collagen deposition and EGFR expression compared to PSW.
Figure 5.
Submucosal and epithelial tissue density of collagen (trichrome staining, collagen; blue) (A-D) and correlations between IL-33 and collagen density in (E) wheeze (square) + STRA (tringle) and non-asthmatic controls (F). Epithelial immunohistochemical staining for EGFR (G-I) in bronchial biopsies from paediatric non-asthmatic controls, wheezers and children with STRA. Since controls and PSW were not age-matched, comparison between non-asthmatic controls < 5 years of age and PSW were analysed separately (K). Paediatric non-asthmatic controls (A,G: n=5), wheezers (B,H: n=5) and children with STRA (C, I: n=8). 5 subjects (2 wheeze and 2 STRA) were excluded due to inadequate tissue sample. Scale bars: A and G: 100 μm. Statistical analysis was performed with Kruskall-Wallis test with Bonferroni post hoc test where *p<0.05 and **<0.01. Correlation analysis was performed using Spearman’s rank correlation where significant differences are considered p<0.05.
IL-33 impaired epithelial wound closing in preschool wheezers compared to controls
In order to investigate cell growth and wound injury in response to IL-33 alone or in combination with poly(I:C), wound closure was measured over 48 hours, using the IncuCyte live-cell imaging system. By comparing area under curve between the groups we found that PSW had significantly lower proliferation and lower wound healing abilities than NA and STRA when stimulated with IL-33 and IL-33 in combination with poly(I:C) (Figure 6A and B). For the percentage of wound closure for each group, see OR, Fig E3.
Figure 6.
Wound-injury assay response at 48h in PBECs from paediatric patients (A) non-asthmatic controls (NA) (n=6), (B) wheezers (n=7) and (C) children with STRA (n=10). PBECs were stimulated with media alone, IL-33, viral mimic poly(I:C) and IL-33 and poly(I:C) in combination. Area under curve (AUC) was calculated for proliferative capacity (A) and wound-healing ability (B). Statistical analysis was performed with Kruskall-Wallis test with Bonferroni post hoc test for each time point. * denotes differences to media control. # denotes differences to STRA. *p<0.05 was considered significant.
Discussion
Bronchial epithelial cells from preschool children with severe recurrent wheeze had reduced proliferative capacity compared to older children with STRA and non-asthmatic controls at baseline and when stimulated with allergen HDM and viral mimic poly(I:C). Furthermore, PSW had reduced epithelial proliferative and wound-healing capacity in response to IL-33. The significantly reduced expression of EGFR in PSW alone suggests an intrinsic defect in the epithelium of children with PSW, and an altered capacity to heal following epithelial injury may lead to reduced epithelial barrier function and exaggerated remodeling (31).
Repair of a damaged epithelium is a crucial part of restoring airway function to its normal state. It involves migration and spreading of epithelial cells into the damaged region and proliferation of new epithelial cells (35, 36). In a study using bronchial biopsies, epithelial injury without significant eosinophilic inflammation, has been observed in childhood asthma (34). Furthermore, dysregulated repair in response to mechanical wounding of the epithelium in paediatric asthmatics has been previously described (16, 37). This indicates an intrinsic reduced ability to respond appropriately to injuries. Our study shows that even younger children with severe preschool wheeze have impaired epithelial proliferation in response to the viral mimic poly(I:C) and allergen HDM. PSW also showed lower proliferation when stimulated with the combination of the two, a condition that experimentally mimics a wheeze attack. We also found that epithelial cells from wheezers had diminished wound-healing capacity at baseline, further indicating an intrinsic impaired ability to repair epithelial damage. Thus, the airway epithelium in severe preschool wheezers appears predisposed to damage by harmful stimuli, such as viral infections or allergens, compared to a healthy epithelium, ultimately leading to the pathological abnormalities including airway remodelling (increased thickness of the reticular basement membrane) that have been described (14, 31, 38). In our model, poly(I:C) alone did not have an effect on wound gap closure in PBECs from PSW. Poly(I:C) lowered wound gap closure also in non-asthmatic controls compared to baseline (approximately 20% decrease, p=0.03). Bronchial epithelial cells from healthy individuals respond to poly(I:C) with for example production of inflammatory mediators and poly(I:C) have been shown to induce cell death and damage in HBECs from normal individuals which might affect their ability to heal wounds (39) by affecting proliferation and growth. However, we saw an increased wound gap closure in all groups when treated with HDM compared to media alone. Closing of a wound gap by bronchial epithelial cells are dependent on both proliferation and migration of the cells (40). HDM has been found to contain proteases that could cleave cell-to-cell and cell-to-surface binding as well as via protease activating receptor (PAR)-2 promote epithelial cell migration (41, 42).
It has been shown that bronchial epithelial cells from children with STRA elicit ineffective antiviral response to RV infection. Although RSV gave rise to equal viral load in all groups, PSW and STRA patients responded in a heightened way for some cytokines. We have shown that preschool wheezers and children with STRA had increased gene expression of pattern recognition receptors in response to RSV with and without concomitant stimulation with HDM compared to controls. This might explain the heightened response for some of the cytokines in PSW and STRA. We used RSV because of epidemiological data that shows RSV infection is associated with hospitalisation and severe recurrent wheeze, but in future could expand to include RV (44, 45). However, children are exposed to multiple viruses across the life course therefore we also used poly(I:C) as a viral mimic to examine wound injury via live-cell imaging. Poly(I:C) showed an impaired effect on cell proliferation in both STRA and PSW which indicates a widespread change in response to TLR3 agonism that is unlikely to be pathogen specific.
We have shown that preschool children with severe wheeze and school-aged children with STRA exhibited an augmented response of both Th1 and Th2 cytokines to RSV with and without concomitant stimulation with HDM. One important feature that distinguished epithelial cells from children with STRA compared to preschool wheeze was the increased production of GRO and IL-8 only in STRA compared to controls. These chemokines are crucial for generating an appropriate neutrophilic response towards pathogens (46). We have previously shown that a subpopulation of children with STRA are characterised by an increased density of intra-epithelial neutrophils that correlated to better lung function, better asthma control and lower dose of maintenance inhaled steroids (47). Results from the current study support our previous findings that intra-epithelial neutrophils might be beneficial during STRA associated pathology. To further investigate the connection to inflammatory response all parameters (proliferation, wound-healing, gene/protein expression and tissue expression of IL-33, ST2, EGFR and collagen) was correlated to levels of eosinophils and neutrophils bronchioalveolar lavage or blood. However, no meaningful strong correlations were found.
Injury to epithelial surfaces triggers release of a variety of pro-inflammatory and Th2-promoting innate cytokines, including IL-25, IL-33, and TSLP (13, 48). Elevated IL-33 levels correlate with increased asthma severity in children, and expression of IL-33 correlates with airway hyper-responsiveness and remodelling in asthma (30, 49, 50). In the present study, we were able to confirm our previous finding of increased submucosal IL-33+ cells in children with STRA (30), but have shown for the first time, that submucosal IL-33 expression was not increased in preschool wheeze. Looking specifically at the epithelial compartment, we found no difference in epithelial IL-33 expression between any of the groups, in contrast to previous reports in adults (50). Furthermore, we could not detect any differences in IL-33 secretion, protein or mRNA, in our cultured epithelial cells at baseline or in response to RSV. The inability to detect IL-33 may be due to the time point, since IL-33 has been shown to be secreted and rapidly oxidised after stimulation (51, 52). The airway samples in our study were collected during stable disease, which may also reflect the expression pattern of IL-33 in the epithelium. IL-33 binds to a receptor complex consisting of two transmembrane proteins: IL-1R1 (ST2) and IL-1RAcP. Our previous study of neonatal ST2 knockout mice showed that HDM activation of the IL-33/ST2 pathway is important for the development of airway hyper-responsiveness with reduced airway remodelling (30). However, to our knowledge ST2 expression in human bronchial epithelium in children with PSW or STRA has not been reported. We detected an increase in ST2 expression in both submucosa and epithelium in STRA, but not PSW, compared to controls. We therefore determined the expression of ST2 in cultured PBECs in response to RSV and HDM and found that protein expression of ST2 increased in both wheezers and STRA compared to controls when stimulated with RSV+HDM. Our results suggest a higher responsiveness in wheezers and STRA during virally induced asthma exacerbations. The gradual increase in ST2 expression, from post viral stimulation in preschool wheeze, to constantly expressed in STRA might also be an indicator of disease progression and severity.
Little is known about the effect of IL-33 on epithelial wound injury in children. IL-33–mediated activation of ILCs induced production of amphiregulin, a ligand for the epidermal growth factor receptor (EGFR) which promotes collagen production and remodelling (53) and induced proliferation and differentiation in epithelial cells during infection (54). In our study, we were able to confirm a correlation between epithelial expression of EGFR and collagen deposition in the submucosa of PSW and STRA children. We also showed a positive association between IL-33 expression and collagen deposition in wheeze and STRA patients. Additionally, PBECs from wheezy children had an impaired wound healing and proliferative capacity in response to IL-33. The different effects of IL-33 in preschool wheezers and STRA compared to healthy controls may explain why wheezing/asthmatic children are more susceptible or have an exaggerated response to virus and allergens.
The wheeze patients had lower EGFR expression than both STRA and controls, which may affect their proliferative and migrative ability (55). EGFR has multiple ligands, therefore investigating the expression and effects of these ligands on bronchial epithelial cell function and airway remodelling in patients with severe PSW and STRA is an important avenue to pursue for potential novel therapeutic targets, particularly since EGFR inhibitors are already available as anti-cancer therapies. We acknowledge that our control and PSW groups are small and not age matched and conclusions might be limited. However, it is exceedingly challenging to have young children undergoing clinical bronchoscopy and moreover to obtain parental consent for extra samples to be taken for research. Hence, the number of patients we can recruit is very limited. To compensate for the age mismatch, EGFR tissue expression in PSW (mean age 2 years) was compared to a subgroup of age-matched non-wheezers (mean age 2.7 years) which confirmed that EGFR expression remained significantly lower in wheezers, suggesting a true disease effect. This suggests that duration of disease, since diagnosis of asthma is established at school-age, may affect EGFR expression.
In conclusion, bronchial epithelial cells from children with severe, recurrent wheeze had lower proliferative capacity at baseline and in response to HDM and viral mimic poly(I:C), alone and in combination. The reduced epithelial EGFR expression in PSW, together with lower wound healing response to IL-33 and common allergen HDM may lead to a damaged epithelial barrier function in early life in preschool wheezers and contribute to the development of airway remodelling and asthma pathogenesis.
Acknowledgements
We thank all the patients and their families for agreeing to take part in our study. We thank Lorraine Lawrence for histology support. We thank Prof Stephen Durham and group members for support with the Milliplex assay. We are also grateful to the Paediatric Respiratory Consultants at the Royal Brompton Hospital for their help in sample collection during the bronchoscopies.
Funding
Swedish Society for Medical Research, Asthma UK, grant ID: 11/050, Wellcome Trust. PR was an NIHR Academic Clinical Fellow and had an NHLI Masters Scholarship. AB was supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust and Imperial College London and is an NIHR Senior Investigator Emeritus. SS is an NIHR Career Development Fellow. CML is a Wellcome Senior Fellow in Basic Biomedical Sciences.
Footnotes
Conflict of Interest Statement: All authors declare that they have no conflicts of interest.
Author contributions: Conception and design: CA, JI, SS, CL; Analysis and data acquisition: CA, JI, PR, JC, PN, SM, LF. Interpretation of data: CA, JI, PN, AB, SS, CL; Drafting the manuscript for important intellectual content: CA, JI, AB, SS, CL
References
- 1.Schultz A, Brand PL. Phenotype-directed treatment of pre-school-aged children with recurrent wheeze. J Paediatr Child Health. 2012;48(2):E73–8. doi: 10.1111/j.1440-1754.2011.02123.x. [DOI] [PubMed] [Google Scholar]
- 2.Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000;161(5):1501–7. doi: 10.1164/ajrccm.161.5.9906076. [DOI] [PubMed] [Google Scholar]
- 3.Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354(9178):541–5. doi: 10.1016/S0140-6736(98)10321-5. [DOI] [PubMed] [Google Scholar]
- 4.Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007;119(5):1105–10. doi: 10.1016/j.jaci.2006.12.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Caliskan M, Bochkov YA, Kreiner-Moller E, Bonnelykke K, Stein MM, Du GX, et al. Rhinovirus Wheezing Illness and Genetic Risk of Childhood-Onset Asthma. New Engl J Med. 2013;368(15):1398–407. doi: 10.1056/NEJMoa1211592. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lu S, Hartert TV, Everard ML, Giezek H, Nelsen L, Mehta A, et al. Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood. Pediatr Pulmonol. 2016;51(12):1382–92. doi: 10.1002/ppul.23461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Anderson HM, Lemanske RF, Jr, Evans MD, Gangnon RE, Pappas T, Grindle K, et al. Assessment of wheezing frequency and viral etiology on childhood and adolescent asthma risk. J Allergy Clin Immunol. 2016 doi: 10.1016/j.jaci.2016.07.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008;178(7):667–72. doi: 10.1164/rccm.200802-309OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Bonfield TL, Ross KR. Asthma heterogeneity and therapeutic options from the clinic to the bench. Curr Opin Allergy Clin Immunol. 2012;12(1):60–7. doi: 10.1097/ACI.0b013e32834edb5b. [DOI] [PubMed] [Google Scholar]
- 10.Thomas A, Lemanske RF, Jr, Jackson DJ. Approaches to stepping up and stepping down care in asthmatic patients. J Allergy Clin Immunol. 2011;128(5):915–24. doi: 10.1016/j.jaci.2011.07.014. quiz 25-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lang A, Carlsen KH, Haaland G, Devulapalli CS, Munthe-Kaas M, Mowinckel P, et al. Severe asthma in childhood: assessed in 10 year olds in a birth cohort study. Allergy. 2008;63(8):1054–60. doi: 10.1111/j.1398-9995.2008.01672.x. [DOI] [PubMed] [Google Scholar]
- 12.Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–73. doi: 10.1183/09031936.00202013. [DOI] [PubMed] [Google Scholar]
- 13.Ritchie AI, Jackson DJ, Edwards MR, Johnston SL. Airway Epithelial Orchestration of Innate Immune Function in Response to Virus Infection. A Focus on Asthma. Ann Am Thorac Soc. 2016;13(Suppl 1):S55–63. doi: 10.1513/AnnalsATS.201507-421MG. [DOI] [PubMed] [Google Scholar]
- 14.Barbato A, Turato G, Baraldo S, Bazzan E, Calabrese F, Panizzolo C, et al. Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med. 2006;174(9):975–81. doi: 10.1164/rccm.200602-189OC. [DOI] [PubMed] [Google Scholar]
- 15.Montefort S, Roberts JA, Beasley R, Holgate ST, Roche WR. The site of disruption of the bronchial epithelium in asthmatic and non-asthmatic subjects. Thorax. 1992;47(7):499–503. doi: 10.1136/thx.47.7.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Stevens PT, Kicic A, Sutanto EN, Knight DA, Stick SM. Dysregulated repair in asthmatic paediatric airway epithelial cells: the role of plasminogen activator inhibitor-1. Clin Exp Allergy. 2008;38(12):1901–10. doi: 10.1111/j.1365-2222.2008.03093.x. [DOI] [PubMed] [Google Scholar]
- 17.Henderson J, Hilliard TN, Sherriff A, Stalker D, Al Shammari N, Thomas HM. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol. 2005;16(5):386–92. doi: 10.1111/j.1399-3038.2005.00298.x. [DOI] [PubMed] [Google Scholar]
- 18.Ruotsalainen M, Hyvarinen MK, Piippo-Savolainen E, Korppi M. Adolescent asthma after rhinovirus and respiratory syncytial virus bronchiolitis. Pediatr Pulmonol. 2013;48(7):633–9. doi: 10.1002/ppul.22692. [DOI] [PubMed] [Google Scholar]
- 19.Sigurs N, Aljassim F, Kjellman B, Robinson PD, Sigurbergsson F, Bjarnason R, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax. 2010;65(12):1045–52. doi: 10.1136/thx.2009.121582. [DOI] [PubMed] [Google Scholar]
- 20.Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Bjorksten B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics. 1995;95(4):500–5. [PubMed] [Google Scholar]
- 21.Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005;171(2):137–41. doi: 10.1164/rccm.200406-730OC. [DOI] [PubMed] [Google Scholar]
- 22.Aberle JH, Aberle SW, Dworzak MN, Mandl CW, Rebhandl W, Vollnhofer G, et al. Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med. 1999;160(4):1263–8. doi: 10.1164/ajrccm.160.4.9812025. [DOI] [PubMed] [Google Scholar]
- 23.Caballero MT, Serra ME, Acosta PL, Marzec J, Gibbons L, Salim M, et al. TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization. J Clin Invest. 2015;125(2):571–82. doi: 10.1172/JCI75183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Renzi PM, Turgeon JP, Marcotte JE, Drblik SP, Berube D, Gagnon MF, et al. Reduced interferon-gamma production in infants with bronchiolitis and asthma. Am J Respir Crit Care Med. 1999;159(5 Pt 1):1417–22. doi: 10.1164/ajrccm.159.5.9805080. [DOI] [PubMed] [Google Scholar]
- 25.Aoyagi M, Shimojo N, Sekine K, Nishimuta T, Kohno Y. Respiratory syncytial virus infection suppresses IFN-gamma production of gamma delta T cells. Clinical and experimental immunology. 2003;131(2):312–7. doi: 10.1046/j.1365-2249.2003.02062.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kalinowski A, Galen BT, Ueki IF, Sun Y, Mulenos A, Osafo-Addo A, et al. Respiratory syncytial virus activates epidermal growth factor receptor to suppress interferon regulatory factor 1-dependent interferon-lambda and antiviral defense in airway epithelium. Mucosal Immunol. 2018;11(3):958–67. doi: 10.1038/mi.2017.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Jackson DJ, Makrinioti H, Rana BM, Shamji BW, Trujillo-Torralbo MB, Footitt J, et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med. 2014;190(12):1373–82. doi: 10.1164/rccm.201406-1039OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Beale J, Jayaraman A, Jackson DJ, Macintyre JD, Edwards MR, Walton RP, et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med. 2014;6(256):256ra134. doi: 10.1126/scitranslmed.3009124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Saglani S, Fleming L, Sonnappa S, Bush A. Advances in the aetiology, management, and prevention of acute asthma attacks in children. Lancet Child Adolesc Health. 2019;3(5):354–64. doi: 10.1016/S2352-4642(19)30025-2. [DOI] [PubMed] [Google Scholar]
- 30.Saglani S, Lui S, Ullmann N, Campbell GA, Sherburn RT, Mathie SA, et al. IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J Allergy Clin Immunol. 2013;132(3):676–85.:e13. doi: 10.1016/j.jaci.2013.04.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Saglani S, Payne DN, Zhu J, Wang Z, Nicholson AG, Bush A, et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med. 2007;176(9):858–64. doi: 10.1164/rccm.200702-212OC. [DOI] [PubMed] [Google Scholar]
- 32.Turato G, Barbato A, Baraldo S, Zanin ME, Bazzan E, Lokar-Oliani K, et al. Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma. Am J Respir Crit Care Med. 2008;178(5):476–82. doi: 10.1164/rccm.200712-1818OC. [DOI] [PubMed] [Google Scholar]
- 33.Weitoft M, Andersson C, Andersson-Sjoland A, Tufvesson E, Bjermer L, Erjefalt J, et al. Controlled and uncontrolled asthma display distinct alveolar tissue matrix compositions. Respir Res. 2014;15:67. doi: 10.1186/1465-9921-15-67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Fedorov IA, Wilson SJ, Davies DE, Holgate ST. Epithelial stress and structural remodelling in childhood asthma. Thorax. 2005;60(5):389–94. doi: 10.1136/thx.2004.030262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Grainge CL, Davies DE. Epithelial injury and repair in airways diseases. Chest. 2013;144(6):1906–12. doi: 10.1378/chest.12-1944. [DOI] [PubMed] [Google Scholar]
- 36.Zahm JM, Kaplan H, Herard AL, Doriot F, Pierrot D, Somelette P, et al. Cell migration and proliferation during the in vitro wound repair of the respiratory epithelium. Cell Motil Cytoskeleton. 1997;37(1):33–43. doi: 10.1002/(SICI)1097-0169(1997)37:1<33::AID-CM4>3.0.CO;2-I. [DOI] [PubMed] [Google Scholar]
- 37.Kicic A, Hallstrand TS, Sutanto EN, Stevens PT, Kobor MS, Taplin C, et al. Decreased fibronectin production significantly contributes to dysregulated repair of asthmatic epithelium. Am J Respir Crit Care Med. 2010;181(9):889–98. doi: 10.1164/rccm.200907-1071OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Saglani S, Lloyd CM. Novel concepts in airway inflammation and remodelling in asthma. Eur Respir J. 2015;46(6):1796–804. doi: 10.1183/13993003.01196-2014. [DOI] [PubMed] [Google Scholar]
- 39.Lever AR, Park H, Mulhern TJ, Jackson GR, Comolli JC, Borenstein JT, et al. Comprehensive evaluation of poly(I:C) induced inflammatory response in an airway epithelial model. Physiol Rep. 2015;3(4) doi: 10.14814/phy2.12334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Gandhi VD, Vliagoftis H. Airway epithelium interactions with aeroallergens: role of secreted cytokines and chemokines in innate immunity. Front Immunol. 2015;6:147. doi: 10.3389/fimmu.2015.00147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ramu S, Menzel M, Bjermer L, Andersson C, Akbarshahi H, Uller L. Allergens produce serine proteases-dependent distinct release of metabolite DAMPs in human bronchial epithelial cells. Clin Exp Allergy. 2018;48(2):156–66. doi: 10.1111/cea.13071. [DOI] [PubMed] [Google Scholar]
- 42.Alturkistani A, Ghonem N, Power-Charnitsky VA, Pino-Figueroa A, Migliore MM. Inhibition of PAR-1 Receptor Signaling by Enoxaparin Reduces Cell Proliferation and Migration in A549 Cells. Anticancer Res. 2019;39(10):5297–310. doi: 10.21873/anticanres.13723. [DOI] [PubMed] [Google Scholar]
- 43.Edwards MR, Regamey N, Vareille M, Kieninger E, Gupta A, Shoemark A, et al. Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol. 2013;6(4):797–806. doi: 10.1038/mi.2012.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Garcia CG, Bhore R, Soriano-Fallas A, Trost M, Chason R, Ramilo O, et al. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics. 2010;126(6):e1453–60. doi: 10.1542/peds.2010-0507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143(5 Suppl):S127–32. doi: 10.1067/s0022-3476(03)00510-9. [DOI] [PubMed] [Google Scholar]
- 46.Chung KF. Cytokines as targets in chronic obstructive pulmonary disease. Curr Drug Targets. 2006;7(6):675–81. doi: 10.2174/138945006777435263. [DOI] [PubMed] [Google Scholar]
- 47.Andersson CK, Adams A, Nagakumar P, Bossley C, Gupta A, De Vries D, et al. Intra-epithelial Neutrophils in Paediatric Severe Asthma are Associated with Better Lung Function. J Allergy Clin Immunol. 2016 doi: 10.1016/j.jaci.2016.09.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Gavala ML, Bashir H, Gern JE. Virus/allergen interactions in asthma. Curr Allergy Asthma Rep. 2013;13(3):298–307. doi: 10.1007/s11882-013-0344-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Castanhinha S, Sherburn R, Walker S, Gupta A, Bossley CJ, Buckley J, et al. Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33. J Allergy Clin Immunol. 2015;136(2):312–22.:e7. doi: 10.1016/j.jaci.2015.01.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Prefontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, Chakir J, et al. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol. 2010;125(3):752–4. doi: 10.1016/j.jaci.2009.12.935. [DOI] [PubMed] [Google Scholar]
- 51.Uchida M, Anderson EL, Squillace DL, Patil N, Maniak PJ, Iijima K, et al. Oxidative stress serves as a key checkpoint for IL-33 release by airway epithelium. Allergy. 2017;72(10):1521–31. doi: 10.1111/all.13158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Kearley J, Silver JS, Sanden C, Liu Z, Berlin AA, White N, et al. Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection. Immunity. 2015;42(3):566–79. doi: 10.1016/j.immuni.2015.02.011. [DOI] [PubMed] [Google Scholar]
- 53.Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol. 2011;12(11):1045–54. doi: 10.1031/ni.2131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Zaiss DMW, Gause WC, Osborne LC, Artis D. Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. Immunity. 2015;42(2):216–26. doi: 10.1016/j.immuni.2015.01.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Holgate ST. Epithelial damage and response. Clin Exp Allergy. 2000;30(Suppl 1):37–41. doi: 10.1046/j.1365-2222.2000.00095.x. [DOI] [PubMed] [Google Scholar]






